(NYSE: ATR) Aptargroup's forecast annual revenue growth rate of 4.9% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.17%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.34%.
Aptargroup's revenue in 2026 is $3,872,744,000.On average, 10 Wall Street analysts forecast ATR's revenue for 2026 to be $256,749,131,268, with the lowest ATR revenue forecast at $247,750,466,712, and the highest ATR revenue forecast at $268,364,428,780. On average, 10 Wall Street analysts forecast ATR's revenue for 2027 to be $269,194,092,888, with the lowest ATR revenue forecast at $258,153,178,220, and the highest ATR revenue forecast at $283,298,382,724.
In 2028, ATR is forecast to generate $287,191,422,000 in revenue, with the lowest revenue forecast at $274,235,897,852 and the highest revenue forecast at $303,593,243,212.